Driving change through partnerships
Together with UNICEF, we are working to prevent childhood overweight and obesity so that more children have the opportunity to live healthy lives.
Diabetes Awareness Month
To help children and their parents manage type 1 diabetes better, Betty and her friend, Penny the Pen, break down how to use an insulin pen into 5 easy steps.
About Us
Discovering, developing and delivering
For more than 100 years, we have been translating the unmet medical needs of people living with a serious chronic disease into innovative medicines and delivery systems, like our insulin pens.
Our treatments today are benefiting millions of people living with diabetes, obesity, and rare blood and endocrine diseases.
From our labs to our factory floors, we are discovering and developing innovative biological medicines and making them accessible to patients throughout the world.
Working with Diversity & Inclusion
We believe diversity and inclusion help drive our innovation and lead to better and more nuanced decisions.
INVESTORS
Share price
30.11.2023 02:49
DKK
Quick links
Latest news
02 November 2023
Novo Nordisk’s sales increased by 29% in Danish kroner and by 33% at constant exchange rates to DKK 166.4 billion in the first nine months
10 November 2023
Novo Nordisk invests more than 42 billion Danish kroner in expansion of manufacturing facilities in Kalundborg, Denmark
23 November 2023
Novo Nordisk invests more than 16 billion Danish kroner in expansion of production facilities in Chartres, France
Career Opportunities
Here are our current job openings. If there is not a job you are looking for, you are welcome to create a job agent or a candidate profile.
